Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set

ConclusionsPatients with AS treated with TNFis had higher incidence rates of IBD, uveitis and sleep apnoea after initiation of TNFi therapy than patients not treated with TNFi therapy.

Source: Journal of Pharmaceutical Health Services Research - December 1, 2017 Category: Drugs & Pharmacology Authors: Jessica A. Walsh, Xue Song, Gilwan Kim, Yujin Park Tags: Research Paper Source Type: research